Lectins Are the Sparkle of Hope for Combating Coronaviruses and the Global COVID 19

Author:

Abbas Heba S.1ORCID,K Muddukrishnaiah2

Affiliation:

1. Microbiology Department, National Organization for Drug Control and Research (NODCAR), Egyptian Drug Authority, Giza, Egypt.

2. Department of Pharmaceutical Technology, Bharathidasan Institute of Technology, Anna University, Tiruchirappalli-620024.Tamilnadu, India.

Abstract

Today the crisis of coronavirus disease 2019 (COVID-19) pandemic represents a threat worldwide because it is a leading cause of human morbidity and mortality. Besides, it possesses a destroying impact on countries’ economies. Therefore, there is an urgent need for hard research work and global collaboration to find a potential therapy. In this review, structural genomic variations in COVID 19 and further therapeutic options of Coronaviridae family or COVID 19 are expressed. Lectins are natural proteins, which can exist in algae, higher plants, banana, actinomycetes, fungi, and archaea, and they have antiviral properties. Griffithsin lectin, isolated from red algae, has noteworthy efficacy against lethal SARS-CoV infection, human coronaviruses, and other animal coronaviruses. Furthermore, all mannose-specific plant lectins have anti-coronaviruses properties except for garlic lectins. However, lectins from mushrooms can act as immunomodulators by activating T-lymphocyte or stimulating dendrites or cytokines. The lectin may hinder glucans on viral spike protein and prevent entry and the virus's release. Lectin's anti-coronavirus activities include a glimmer of hope to tackle the global COVID 19 crisis and inspire more scientific work on carbohydrate-binding agents against SARS-CoV-2.

Publisher

Maad Rayan Publishing Company

Subject

General Pharmacology, Toxicology and Pharmaceutics,Pharmaceutical Science

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3